SPRY - ARS Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$25.50
DETAILS
HIGH:
$26.00
LOW:
$25.00
MEDIAN:
$25.50
CONSENSUS:
$25.50
UPSIDE:
221.16%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 75.8% |
| EBIT Margin | -212.9% |
| EBITDA Margin | -211.3% |
| Operating Margin | -212.9% |
| Pretax Margin | -203.3% |
| Cont. Ops Margin | -203.3% |
| Net Margin | -203.3% |
| Bottom Line Margin | -203.3% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 7.28 |
| Quick Ratio | 7.06 |
| Solvency Ratio | -0.796 |
| Cash Ratio | 1.06 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings | |
| PEG Ratio | 0.00 |
| Forward PEG | 0.00 |
| Price/Book | 10.05 |
| Price/Sales | 13.63 |
| Price/FCF | -6.71 |
| Price/Op Cash Flow | -6.72 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.2959 |
| Debt/Equity | 0.8486 |
| Debt/Capital | 0.4591 |
| Long-Term Debt/Capital | 0.4575 |
| Financial Leverage | 2.87 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.30 |
| Operating Cash Flow Ratio | -4.365 |
| Operating Cash Flow/Sales | -202.7% |
| Free Cash Flow/Operating Cash Flow | 100.2% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -55.85 |
| Interest Coverage | -69.0450 |
| Short-Term Operating Cash Flow Coverage | -290.59 |
| Operating Cash Flow Coverage | -1.76 |
| Capital Expenditure Coverage | -504.03 |
| Dividend + Capital Expenditure Coverage | -504.03 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.86 |
| EPS | -1.738 |
| Debt/Share | 1.0101 |
| Cash/Share | 2.49 |
| Book Value/Share | 1.16 |
| Tangible BV/Share | 1.01 |
| Equity/Share | 1.16 |
| Operating Cash Flow/Share | -1.734 |
| Capital Expenditure/Share | 0.003 |
| FCF/Share | -1.737 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.955 |
| Price/Fair Value | 10.05 |
| Debt/Market Cap | 0.0844 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -6.76 |